Alla Lisyankaya, MD, PhD
Alla Lisyankaya, MD, PhD
Head
St. Petersburg City Oncology Hospital
City Oncology College Dispensary
Saint Petersburg
Russia
198255
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)